Cellebrite Q2 GAAP net income drops to USD 6.4 million; revenue rises 16% to USD 131.1 million
CLBT•Quarterly results
Cellebrite posted Q2 2026 revenue of USD 131.1 million, up 16% year over year; GAAP net income fell to USD 6.4 million.
Total ARR climbed 21% to USD 507.8 million; dollar-based net retention rate rose 2 percentage points to 117%.
Adjusted EBITDA increased to USD 31.8 million, lifting the margin to 24.2%; management cited longer sales cycles and weaker Inseyets expansion.
Updated full-year outlook
FY 2026 outlook was cut for ARR to USD 550 million-USD 560 million and revenue to USD 555 million-USD 561 million; the adjusted EBITDA target was raised to USD 153 million-USD 159 million.
Management and product updates
Shiven Ramji succeeded Thomas E. Hogan as CEO.
Genesis agentic AI launched in June began early monetization, with a first significant FedRAMP Guardian deal signed.
